to
About
Wednesday 14 April, 4-5pm
Dr Stuart Peltz, CEO of PTC Therapeutics Inc. USA, will discuss the development of therapeutics based on RNA biology, especially in relation to the treatment of rare diseases. This webinar will be chaired by Prof Anne Willis OBE, co-director of CATS and the Director of the MRC Toxicology Unit. Please, register here